Latest NVP Associates, LLC Stock Portfolio
NVP Associates, LLC Performance:
2025 Q3: 0.78%YTD: 81.87%2024: -0.65%
Performance for 2025 Q3 is 0.78%, and YTD is 81.87%, and 2024 is -0.65%.
About NVP Associates, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, NVP ASSOCIATES, LLC reported an equity portfolio of $166.1 Millions as of 30 Sep, 2025.
The top stock holdings of NVP ASSOCIATES, LLC are , , . The fund has invested 33.7% of it's portfolio in OMADA HEALTH INC and 24.6% of portfolio in ZENAS BIOPHARMA INC.
The fund managers got completely rid off DAVE INC (DAVE) and OPENDOOR TECHNOLOGIES INC (OPEN) stocks.
The top stock holdings of NVP ASSOCIATES, LLC are , , . The fund has invested 33.7% of it's portfolio in OMADA HEALTH INC and 24.6% of portfolio in ZENAS BIOPHARMA INC.
The fund managers got completely rid off DAVE INC (DAVE) and OPENDOOR TECHNOLOGIES INC (OPEN) stocks.
NVP Associates, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that NVP ASSOCIATES, LLC made a return of 0.78% in the last quarter. In trailing 12 months, it's portfolio return was 126.23%.
New Buys
Additions
Reductions
Sold off
| Ticker | $ Sold |
|---|---|
| opendoor technologies inc | -2,233,040 |
| dave inc | -62,452,300 |
NVP Associates, LLC got rid off the above stocks
Sector Distribution
NVP ASSOCIATES, LLC has about 80.8% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 80.8 |
| Healthcare | 16.3 |
| Consumer Defensive | 2.9 |
Market Cap. Distribution
NVP ASSOCIATES, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 80.8 |
| SMALL-CAP | 16.3 |
| MICRO-CAP | 2.9 |
Stocks belong to which Index?
About 0% of the stocks held by NVP ASSOCIATES, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 100 |
NVP Associates, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of NVP Associates, LLC
NVP ASSOCIATES, LLC has 5 stocks in it's portfolio. TALK proved to be the most loss making stock for the portfolio. GROV was the most profitable stock for NVP ASSOCIATES, LLC last quarter.
Last Reported on: 14 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| DAVE | dave inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| GROV | grove collaborative hold inc | 2.91 | 3,225,100 | 4,837,650 | unchanged | 0.00 | ||
| OPEN | opendoor technologies inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| TALK | talkspace inc | 16.29 | 9,802,970 | 27,056,200 | unchanged | 0.00 | ||
| omada health inc | 33.70 | 2,531,000 | 55,960,400 | unchanged | 0.00 | |||
| zenas biopharma inc | 24.58 | 1,838,480 | 40,814,300 | unchanged | 0.00 | |||
| mbx biosciences inc | 22.51 | 2,136,340 | 37,385,900 | unchanged | 0.00 | |||